CDH1 and breast neoplasm: For example, the proto-oncogene ROS1 encodes a receptor tyrosine kinase (ROS1), and a preclinical study of CDH1 synthetic lethality interactions has identified ROS1 as a potential target in breast tumor cells with CRISPR/Cas9-engineered CDH1 mutations [126].